Insight
Life Sciences Snapshot – Q3 2024 – A Quarterly Report on Financing Trends
28 minute read | October.07.2024

28 minute read | October.07.2024
7 minute read | August.05.2024
by Albert Vanderlaan
8 minute read | July.11.2024
Orrick’s Albert Vanderlaan shared tips in a recent First Citizens Bank blog post for companies that may be acquired.
21 minute read | June.26.2024
by Niki Fang, Bill Hughes, Albert Vanderlaan and Soo Hwang
5 minute read | June.25.2024
3 minute read | March.12.2024
Evercore joined us for a conversation on the tech capital markets – from the election year, AI and regulation to the tech IPO playbook.
6 minute read | March.12.2024
25 minute read | February.26.2024
Women's & Reproductive Health
by Alice Hsu, Bill Hughes, Hari Raman, Albert Vanderlaan, Travis Cherry and Bobby Bee
9 minute read | February.01.2024
The Securities and Exchange Commission (the “SEC”) has finalized its long-awaited rules regarding special purpose acquisition companies (“SPAC”).
by Albert Vanderlaan
2 minute read | January.31.2024
Many private companies have not kept up with recent changes affecting when certain disclosures or reports may be required.
by Stephen Thau, Albert Vanderlaan and George Pothoulakis
6 minute read | January.30.2024
Reverse mergers have helped biotech companies access public markets, but recent SEC positions are threatening that path to going public.
by Kelly A. Mink, Bobby Bee, Bill Hughes and Albert Vanderlaan
1 minute read | January.11.2024